Skip to main content

Table 2 Stenting as bail-out treatment of vasospasm after aSAH: loading medication, stent dimensions, target vessel, vessel segment, Nimodipine IV after stenting, thrombus formation, bleeding complication

From: Intracranial stenting as a bail-out option for posthemorrhagic cerebral vasospasm: a single-center experience with long-term follow-up

Patient number Group Loading medication Stent dimensions Target vessel Vessel segments (diameters in mm) Nimodipine IV after stenting (days) Thrombus after stenting Peri- or postprocedural bleeding
1 1 1 × 500 mg ASA
1 × 75 mg PRA
Solitaire
4/15
ACA rt A1-A2 (0.7–0.5 mm) Yes (14 days) no no
2 1 1 × 4 mg EPT
2 × 500 mg ASA
1 × 600 mg CLO
LVIS Jr
2.5/24
MCA rt ICA-M1-M2 (1–0.7–0.4 mm) Yes (7 days) Transient Thrombus formation resolved: EPT IA no
3 2 1 × 500 mg ASA
1 × 30 mg PRA
Enterprise
4/39
MCA rt M1-M2 (0.4–0.5 mm) Yes (9 days) no no
4 2 1 × 12.4 mg EPT
1 × 500 mg ASA
1 × 180 mg TIC
Enterprise2
4/30
MCA rt M1-M2 (0.3–0.7 mm) Yes (19 days) no no
5 2 1 × 500 mg ASA
1 × 10 mg PRA
Enterprise2
4/16
1 × Enterprise2
4/23
MCA rt
ACA rt
M1 (0.7 mm)
A1-A2 (0.6–0.7 mm)
Yes (11 days) no no
6 2 1 × 12.4 mg EPT
1 × 500 mg ASA
1 × 180 mg TIC
Neuroform Atlas
3/15
Baby Leo
2/12
Neuroform Atlas
4/24
Neuroform Atlas
4.5/30
ACA rt
ACA rt
MCA lt
ICA lt
A2 (0.5 mm)
A1 (0.6 mm)
ICA-M1 (1.7–0.6 mm)
A1-A2 (0.5–0.4 mm)
Yes (8 days) no no